Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 1898 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Consumer-Directed Healthcare

By: MattB
Views: 1862

Medicare Part D Prescription Drug Benefit Overview

By: MattB
Views: 1772

High-Performance Pharma Brand Plans - The 5 Pitfalls to avoid

By: MattB
Views: 2444

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

By: MattB
Views: 1555

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.3

By: MattB
Views: 2546

Evaluate Vantage 2020 Preview – A Report on Pharmaceutical Industry

By: MattB
Views: 2598

Indian API (Active Pharmaceutical Ingredient) Industry - Reaching The Full Potential

By: MattB
Views: 1716

A Blueprint for Improving the Security of the USA Pharmaceutical Supply Chain

By: MattB
Views: 1468

Emerging Biopharma’s Contribution to Innovation

By: docshare
Views: 1351

ANTIBIOTICOS

By: JRMS
Views: 1201

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z